Market Cap 310.26M
Revenue (ttm) 0.00
Net Income (ttm) -55.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.27
Volume 310,300
Avg Vol 731,952
Day's Range N/A - N/A
Shares Out 59.90M
Stochastic %K 25%
Beta 0.83
Analysts Strong Sell
Price Target $9.00

Company Profile

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator th...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 761 4904
Fax: 339 674 6495
Address:
131 Hartwell Avenue, Suite 320, Lexington, United States
Smellmahass
Smellmahass Oct. 25 at 8:52 AM
$ALDX 3rd time to get CRL would be very odd.
1 · Reply
Elegant_Confusion
Elegant_Confusion Oct. 24 at 6:46 PM
$ALDX Eylocity is a great name for a new drug, and nobody’s going to forget it easily! It won’t take much to make Eylocity a household name because millions of patients with Dry Eye are waiting for it, and some go without any treatment because of lack of effective remedies. It’s been a decade and a half since there’s been a new treatment, and patients are clamoring for something that works. Buy more shares now, because approval is less than two months away, and ALDX has already met the clinical endpoints required by the FDA in its CRL! Extremely bullish!
1 · Reply
Milanfinest
Milanfinest Oct. 24 at 2:36 PM
0 · Reply
Elegant_Confusion
Elegant_Confusion Oct. 24 at 8:19 AM
$ALDX time to fill your tank with more shares. They’re getting the marketing ready.
1 · Reply
Bigbas
Bigbas Oct. 23 at 9:46 PM
$ALDX I’m am loaded to the gills with 1/16/26 calls that I bought back in May. If this sucker hits it’s gonna be a heck of a new year!! Positive Vibes on this PDUFA! No CRL, hopefully 🤞,baby!! Question: is AbbVie going to help with commercialization and distribution or will they just take over the whole process and buy Reproxalap since Restasis has lost exclusivity?
2 · Reply
GoldmanSlaps
GoldmanSlaps Oct. 23 at 4:22 PM
$ALDX setting up for a move in November
2 · Reply
RoyBasch
RoyBasch Oct. 23 at 4:07 PM
$ALDX It really doesn’t matter if $ALDX trades at $3, $4, $5, $6 or $7 in the meantime. All noise. All volatility. All the usual rollercoaster before the main event. Everything leads to December 16th — the binary event. FDA says yes → we’re in an entirely different league. FDA says no → you knew the risk from day one. Until then? Expect swings, fear, fake news, short games. But make no mistake — only one date matters.
3 · Reply
Moneymachineuser
Moneymachineuser Oct. 23 at 3:15 PM
$ALDX I will go all in $75K if dips to 3,5
0 · Reply
Milanfinest
Milanfinest Oct. 23 at 2:01 PM
$ALDX stop fixed at 5.04 and sayonara i have a lost opportunity cost on this position that is inenarrable
0 · Reply
AllinDeyra
AllinDeyra Oct. 23 at 12:40 PM
$ALDX give me 7,5 usd, come on... 15-20 with with approval abbvie
0 · Reply
Latest News on ALDX
Aldeyra Therapeutics Appoints Chip Clark to Board of Directors

Apr 17, 2025, 7:00 AM EDT - 6 months ago

Aldeyra Therapeutics Appoints Chip Clark to Board of Directors


Smellmahass
Smellmahass Oct. 25 at 8:52 AM
$ALDX 3rd time to get CRL would be very odd.
1 · Reply
Elegant_Confusion
Elegant_Confusion Oct. 24 at 6:46 PM
$ALDX Eylocity is a great name for a new drug, and nobody’s going to forget it easily! It won’t take much to make Eylocity a household name because millions of patients with Dry Eye are waiting for it, and some go without any treatment because of lack of effective remedies. It’s been a decade and a half since there’s been a new treatment, and patients are clamoring for something that works. Buy more shares now, because approval is less than two months away, and ALDX has already met the clinical endpoints required by the FDA in its CRL! Extremely bullish!
1 · Reply
Milanfinest
Milanfinest Oct. 24 at 2:36 PM
0 · Reply
Elegant_Confusion
Elegant_Confusion Oct. 24 at 8:19 AM
$ALDX time to fill your tank with more shares. They’re getting the marketing ready.
1 · Reply
Bigbas
Bigbas Oct. 23 at 9:46 PM
$ALDX I’m am loaded to the gills with 1/16/26 calls that I bought back in May. If this sucker hits it’s gonna be a heck of a new year!! Positive Vibes on this PDUFA! No CRL, hopefully 🤞,baby!! Question: is AbbVie going to help with commercialization and distribution or will they just take over the whole process and buy Reproxalap since Restasis has lost exclusivity?
2 · Reply
GoldmanSlaps
GoldmanSlaps Oct. 23 at 4:22 PM
$ALDX setting up for a move in November
2 · Reply
RoyBasch
RoyBasch Oct. 23 at 4:07 PM
$ALDX It really doesn’t matter if $ALDX trades at $3, $4, $5, $6 or $7 in the meantime. All noise. All volatility. All the usual rollercoaster before the main event. Everything leads to December 16th — the binary event. FDA says yes → we’re in an entirely different league. FDA says no → you knew the risk from day one. Until then? Expect swings, fear, fake news, short games. But make no mistake — only one date matters.
3 · Reply
Moneymachineuser
Moneymachineuser Oct. 23 at 3:15 PM
$ALDX I will go all in $75K if dips to 3,5
0 · Reply
Milanfinest
Milanfinest Oct. 23 at 2:01 PM
$ALDX stop fixed at 5.04 and sayonara i have a lost opportunity cost on this position that is inenarrable
0 · Reply
AllinDeyra
AllinDeyra Oct. 23 at 12:40 PM
$ALDX give me 7,5 usd, come on... 15-20 with with approval abbvie
0 · Reply
AllinDeyra
AllinDeyra Oct. 23 at 12:25 PM
$ALDX 5,85. +12% hope also After pre market
1 · Reply
Milanfinest
Milanfinest Oct. 23 at 11:08 AM
$ALDX so today while everything bounce we make another + 2/-5 day?
0 · Reply
Milanfinest
Milanfinest Oct. 22 at 3:54 PM
1 · Reply
Milanfinest
Milanfinest Oct. 22 at 2:58 PM
$ALDX it s nice to be optimist
0 · Reply
Tim_Dog
Tim_Dog Oct. 22 at 2:57 PM
$ALDX Stop Loss Raid
1 · Reply
Tim_Dog
Tim_Dog Oct. 22 at 2:52 PM
$ALDX Seems as if the algos walking it down today. 4% drop is a bit much today.
0 · Reply
Milanfinest
Milanfinest Oct. 22 at 10:42 AM
0 · Reply
PeterV9764
PeterV9764 Oct. 21 at 5:22 PM
$ALDX Looks like Abbvie is at the AAO in Orlando! I’m sure they looking forward to get things geared up ….
2 · Reply
RoyBasch
RoyBasch Oct. 21 at 4:33 PM
$ALDX EYLOCITY 🎅🏻 🎄
1 · Reply
GlassEats
GlassEats Oct. 21 at 3:46 PM
$ALDX Careful with this bologna, this company doesn’t have a good rep with FDA and doesn’t lobby enough to get things pushed through. Still have some shares and hoping for the best but history has not been kind and the FDA doesn’t forget.
4 · Reply
TheGodsMustBeCrazy
TheGodsMustBeCrazy Oct. 21 at 3:25 PM
0 · Reply
Milanfinest
Milanfinest Oct. 21 at 1:54 PM
0 · Reply